Does Virginia Medicaid cover Wegovy and Zepbound in 2026?
Only under narrower rules. As of Oct 23, 2026, Virginia Medicaid covers GLP-1 drugs for obesity only under stricter criteria than most states.
Covered with narrower rules Checked Oct 23, 2026 In effect Jul 1, 2026
Coverage of GLP-1 drugs for obesity alone under Virginia’s fee-for-service Medicaid drug rules, as the state publishes them. The plan decides each request.
Virginia’s rule
In plain words
Covered with narrower rules
BMI over 40, or over 37 with high cholesterol, high blood pressure or type 2 diabetes, after a non-GLP-1 weight-loss drug.
Source
DMAS service authorization form, Weight-Loss Management, eff. 07/01/2026 (opens in new tab). Checked Oct 23, 2026.
Federal Medicaid law lets a state exclude these drugs only “when used for anorexia, weight loss, or weight gain”; their use for type 2 diabetes is not on that list, though a state may require prior authorization. Social Security Act §1927(d)(1)(A) and (d)(2)(A), 42 U.S.C. 1396r-8(d) (opens in new tab).
What changed
- Jul 1, 2026: Virginia Medicaid narrowed weight-loss GLP-1 coverage to a BMI over 40, or over 37 with a related condition, after a non-GLP-1 drug. DMAS service authorization form, Weight-Loss Management, eff. 07/01/2026 (opens in new tab)
Next steps
Where to go from here
Neighbouring states
Questions this page answers
Does Virginia Medicaid cover Wegovy and Zepbound for weight loss?
Only under narrower rules. As of Oct 23, 2026, Virginia Medicaid covers GLP-1 drugs for obesity only under stricter criteria than most states. BMI over 40, or over 37 with high cholesterol, high blood pressure or type 2 diabetes, after a non-GLP-1 weight-loss drug.
Has Virginia’s rule changed recently?
Jul 1, 2026: Virginia Medicaid narrowed weight-loss GLP-1 coverage to a BMI over 40, or over 37 with a related condition, after a non-GLP-1 drug.
Where does this information come from?
From DMAS service authorization form, Weight-Loss Management, eff. 07/01/2026, read on Oct 23, 2026. Federal Medicaid law lets a state exclude these drugs only “when used for anorexia, weight loss, or weight gain”; their use for type 2 diabetes is not on that list, though a state may require prior authorization.
Kymata Health reads each state’s own Medicaid documents. See every state on the map.